Scientific founders

David Woldbye

David Woldbye, born 1963, is Associate Professor at the University of Copenhagen, where, among other things, he leads a research group at the Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology. He was the first to demonstrate that NPY has an anti-epileptic effect in vivo, and has published a large number of scientific papers on this subject and related research areas.

Merab Kokaia

Merab Kokaia, born 1956, is Professor of Neurophysiology and heads the Epilepsy Centre, Lund University Faculty of Medicine. In addition to his research collaboration with David Woldbye, concerning NPY and epilepsy, Merab Kokaia has also led breakthrough studies concerning optogenetics and neurotrophins in the context of epilepsy. He also contributed to the scientific discoveries and patented inventions upon which the companies NeuroVive Pharmaceutical AB (publ) and MaasBiolab in the USA were established.